A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Clinical trial NCT01633060 · TERMINATED
Trial details
- NCT number
- NCT01633060
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-03
- Primary completion
- 2016-05-23
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.